Dietary bioflavonoids have been shown to induce mixed-lineage leukemia (MLL) gene cleavage by targeting topoisomerase II, and they might lead to pediatric leukemia (Strick et al., 2000). The gene discussed is KMT2A; the disease is leukemia.